Table 2.
Novel versus practiced trial activity voxel clusters
| Cluster labels | Direction of signal | Hemisphere | Voxels (3.2 mm3) | Talairach coordinate x | Talairach coordinate y | Talairach coordinate z | Areas |
|---|---|---|---|---|---|---|---|
| aPFC | N > P | Left | 148 | −29.4 | 46.6 | 11.5 | 10, 11 |
| DLPFC | P > N | Right | 113 | 25.5 | 28.7 | 29.7 | 9 |
| PMC/M1/S1/A1/IPL/pTL | P > N | Left | 318 | −51.2 | −19.9 | 20.3 | 44, 6, 4, 3, 13, 22, 41, 43, 40 |
| PPC | P > N | Both | 240 | −8 | −52.2 | 58 | 7 |
| PMC/M1/S1/A1/IPL/pTL | P > N | Right | 228 | 57.9 | −24.4 | 21.4 | 40, 6, 22, 41, 42, 21 |
| SMA/CMA | P > N | Both | 204 | −0.9 | −7.6 | 47.9 | 6, 24 |
The contrast was defined by novel trials versus practiced trials (p < 0.05, FWE corrected). P > N, Practiced significantly greater than novel; N > P, novel significantly greater than practiced.